IMIPRAMINE PAMOATE Drug Patent Profile
✉ Email this page to a colleague
When do Imipramine Pamoate patents expire, and what generic alternatives are available?
Imipramine Pamoate is a drug marketed by Hikma, Lupin Ltd, and Rising. and is included in three NDAs.
The generic ingredient in IMIPRAMINE PAMOATE is imipramine pamoate. There are thirty-four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the imipramine pamoate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Imipramine Pamoate
A generic version of IMIPRAMINE PAMOATE was approved as imipramine pamoate by HIKMA on April 16th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for IMIPRAMINE PAMOATE?
- What are the global sales for IMIPRAMINE PAMOATE?
- What is Average Wholesale Price for IMIPRAMINE PAMOATE?
Summary for IMIPRAMINE PAMOATE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 14 |
| Clinical Trials: | 2 |
| Patent Applications: | 1 |
| Drug Prices: | Drug price information for IMIPRAMINE PAMOATE |
| What excipients (inactive ingredients) are in IMIPRAMINE PAMOATE? | IMIPRAMINE PAMOATE excipients list |
| DailyMed Link: | IMIPRAMINE PAMOATE at DailyMed |
Recent Clinical Trials for IMIPRAMINE PAMOATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Shalvata Mental Health Center | N/A |
| Roxane Laboratories | N/A |
Pharmacology for IMIPRAMINE PAMOATE
| Drug Class | Tricyclic Antidepressant |
Anatomical Therapeutic Chemical (ATC) Classes for IMIPRAMINE PAMOATE
US Patents and Regulatory Information for IMIPRAMINE PAMOATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | IMIPRAMINE PAMOATE | imipramine pamoate | CAPSULE;ORAL | 091099-001 | Apr 16, 2010 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Lupin Ltd | IMIPRAMINE PAMOATE | imipramine pamoate | CAPSULE;ORAL | 090444-003 | Apr 16, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hikma | IMIPRAMINE PAMOATE | imipramine pamoate | CAPSULE;ORAL | 091099-004 | Apr 16, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Rising | IMIPRAMINE PAMOATE | imipramine pamoate | CAPSULE;ORAL | 202338-004 | Jun 28, 2013 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lupin Ltd | IMIPRAMINE PAMOATE | imipramine pamoate | CAPSULE;ORAL | 090444-004 | Apr 16, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hikma | IMIPRAMINE PAMOATE | imipramine pamoate | CAPSULE;ORAL | 091099-002 | Apr 16, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hikma | IMIPRAMINE PAMOATE | imipramine pamoate | CAPSULE;ORAL | 091099-003 | Apr 16, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
